跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Tobrazin Plus - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Tobrazin Plus
Approved
STANDARD
Tobrazin Plus
Scott-Edil Pharmacia Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
7451e6ee439b5e8b
Company
Scott-Edil Pharmacia Ltd.
Type
Standard
Approval Details
Approval Id
7451e6ee439b5e8b
Drug Approval Philippines Name
Tobrazin Plus
Product Name
Tobrazin Plus
Registration Number
DRP-15855
Brand Name
Tobrazin Plus
Generic Name
Tobramycin (as sulfate) + Dexamethasone sodium phosphate
Dosage Form
Ophthalmic Solution (Drops)
Dosage Strength
3 mg/1 mg (0.3% / 0.1%) per mL
Manufacturer
Scott-Edil Pharmacia Ltd.
Importer
Greencore Pharma Inc.
Distributor
Greencore Pharma Inc.
Issuance Date
25 September 2024
Expiry Date
25 September 2029
Pharmacologic Category
Antibacterial/Corticosteroid
Classification
Prescription (Rx) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
7451e6ee439b5e8b
Type
Standard
Back to Philippines FDA Approvals